Related references
Note: Only part of the references are listed.EGF Receptor Promotes Prostate Cancer Bone Metastasis by Downregulating miR-1 and Activating TWIST1
Yung-Sheng Chang et al.
CANCER RESEARCH (2015)
The SIX1-EYA transcriptional complex as a therapeutic target in cancer
Melanie A. Blevins et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression
Z-H Liu et al.
CELL DEATH & DISEASE (2015)
PYK2 sustains endosomal-derived receptor signalling and enhances epithelial-to-mesenchymal transition
Nandini Verma et al.
NATURE COMMUNICATIONS (2015)
MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling
Na Huang et al.
ONCOTARGET (2015)
miR-30a suppresses breast cancer cell proliferation and migration by targeting Eya2
Jing Fu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
MicroRNA-338-3p Inhibits Colorectal Carcinoma Cell Invasion and Migration by Targeting Smoothened
Qi Xue et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2014)
Allosteric Inhibitors of the Eya2 Phosphatase Are Selective and Inhibit Eya2-mediated Cell Migration
Aaron B. Krueger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
MicroRNA-338 Inhibits Growth, Invasion and Metastasis of Gastric Cancer by Targeting NRP1 Expression
Yang Peng et al.
PLOS ONE (2014)
MiR-338-3p Inhibits Hepatocarcinoma Cells and Sensitizes These Cells to Sorafenib by Targeting Hypoxia-Induced Factor 1α
Haitao Xu et al.
PLOS ONE (2014)
SGEF enhances EGFR stability through delayed EGFR trafficking from early to late endosomes
Hongtao Wang et al.
CARCINOGENESIS (2013)
miR-20a triggers metastasis of gallbladder carcinoma
Yanxin Chang et al.
JOURNAL OF HEPATOLOGY (2013)
Targeting the ERBB family in cancer: couples therapy
Niall Tebbutt et al.
NATURE REVIEWS CANCER (2013)
Role of epidermal growth factor receptor in breast cancer
Hiroko Masuda et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Signal Transduction Pathways of the Epidermal Growth Factor Receptor in Colorectal Cancer and their Inhibition by Small Molecules
T. Efferth
CURRENT MEDICINAL CHEMISTRY (2012)
Structure-based de novo design of Eya2 phosphatase inhibitors
Hwangseo Park et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2012)
EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers
Michela Garofalo et al.
NATURE MEDICINE (2012)
Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation
P. Dhawan et al.
ONCOGENE (2011)
Epidermal Growth Factor Receptor Expression in Breast Cancer Association With Biologic Phenotype and Clinical Outcomes
Mothaffar F. Rimawi et al.
CANCER (2010)
Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer
Tetsuya Mitsudomi et al.
FEBS JOURNAL (2010)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family
H. Michael Shepard et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models
D. Li et al.
ONCOGENE (2008)
ErbB receptors: from oncogenes to targeted cancer therapies
Hongtao Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications
George A. Calin et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1α signal pathways increases resistance to apoptosis by up-regulating survivin gene expression
Xiang-Hong Peng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A phase I study of cetuximab/paclitaxel in patients with advanced-stage breast cancer
Shanu Modi et al.
CLINICAL BREAST CANCER (2006)
EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms
N Pore et al.
CANCER RESEARCH (2006)
Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells
H Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells
QB She et al.
CANCER CELL (2005)
Breast cancer metastasis: Markers and models
B Weigelt et al.
NATURE REVIEWS CANCER (2005)
Timeline - Gefitinib - a novel targeted approach to treating cancer
RS Herbst et al.
NATURE REVIEWS CANCER (2004)
Ligand-induced, receptor-mediated dimerization and activation of EGF receptor
J Schlessinger
CELL (2002)
Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases
RS Muraoka et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme
JS Smith et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase
ZM Lu et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Share Paper
